Transportation of neuroprotective flavonoids using the BBB, Caco-2 cell model and everted rat intest

来源 :第十届全国药物和化学异物代谢学术会议暨第三届国际ISSX/CSSX联合学术会议 | 被引量 : 0次 | 上传用户:sujie0888
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective Comparative evaluations of cellular toxicity, lipophilicity and in vitro transmembrane transport of eight cerebrovascular protection flavonoids including puerarin, rutin, hesperidin, quercetin, genistein, kaempferol, apigenin and isoliquiritigenin were investigated using rat blood-brain barrier (BBB) ceil, Caco-2 cell monolayer and everted intestine jejunm sac model.Methods The BBB bilayer was successfully co-cultured via rat brain microvascular endothelial cells and astrocytes.The apparent permeability coefficients (Papp) of the flavonoids were calculated from unilateral transport assays in Transwell system with simultaneous determination using a high performance liquid chromatography.The toxicity was determined by the MTT assay.Results The tested flavonoids exhibited time-dependent Papp values in these models, suggesting the transmembrane transport of these compounds by passive diffusion mode.There were some differences in the Papp of the active flavonoids between the BBB cell model and the Caco-2 cell model.The transport of the tested flavonoid could be enhanced when administrated with the flavonoid mixtures.The efflux mechanisms related with P-glycoprotein may exist with some flavonoids.The permeability was correlated to the parental skeleton, the number and position of glycoside and hydroxyl groups of the flavonoids.Conclusion These findings provided important information for establishing the transport relationship and predicting the oral bioavailability of the active flavonoids.
其他文献
目的 研究肾移植术后患者多药耐药相关蛋白(MRP2/ABCC2)基因多态性对环孢素(CsA)肝功能异常的影响.方法 入选的339例肾移植受者均采用CsA治疗,检测患者rs717620 (A/G)和rs2273697 (G/A)多态性的基因型.此外,采用荧光偏振免疫法检患者的CsA血药浓度,根据肾移植患者发生肝脏损伤的情况分为3组.结果 rs717620和rs2273697突变等位基因发生频率分别为
目的 建立测定芦荟大黄素、大黄酸、大黄素、大黄酚、大黄素甲醚五种游离葸醌成分与大鼠血浆蛋白结合率的方法.方法 采用体外平衡透析法,模拟五种游离蒽醌成分与血浆蛋白的结合过程,以固相萃取柱处理血浆样品,用高效液相色谱法进行测定五种游离葸醌类成分在透析袋内血浆中的质量浓度与透析袋外缓冲液中的质量浓度.结果 计算血浆蛋白结合率.芦荟大黄素、大黄酸、大黄素、大黄酚、大黄素甲醚提取回收率分别为68.6%、91
目的 延胡索乙素(THP)、原阿片碱(PRO)和去氢紫堇碱(DHC)为延胡索主要活性成分。本研究旨在考察三种成分与CYP450s/P-gp相互作用,为药物间相互作用(DDI)的预测以及临床用药的安全性评价提供理论和数据支持。方法 运用P450-GloTM Screening Systems和混合人肝微粒体(HLMs)研究THP、PRO和DHC对5种CYP450s代谢酶的抑制机制和代谢机制;运用MD
目的 阐明薯蓣皂苷(dioscin)经肝脏转运体摄取的药代动力学特征.方法 建立灵敏、快速、高效的LC-MS/MS内标法检测生物样品中dioscin和地高辛的浓度及含量.分别采用大鼠体内LUI法、在体肝灌流、体外肝切片、游离肝细胞及人转染细胞摄取和转运实验考察dioscin经肝脏转运体摄取的药动学特征.结果 LUI及肝灌流实验与单独给药相比,合用有机阴离子转运多肽(OATPs)抑制剂环孢素和利福平
阿帕替尼(N-J4-(氰基环戊基)苯基][2-[(4-毗啶甲基)氨基](3-吡啶)]甲酰胺)是一种选择性的内皮生长因子受体-2抑制剂,目前在中国处于Ⅱ/Ⅲ期临床开发阶段,用于多种实体瘤的治疗.本实验目的是研究经口服给药后阿帕替尼在人体内的代谢、排泄和药动学.受试者血浆、尿、粪经超高效液相色谱-四极杆串联飞行时间质谱法检测代谢物.8个主要代谢物经化学合成或从尿样分离得到对照品确证结构.阿帕替尼在人体
目的 利用H9c2心肌细胞模型,阐明23-羟基白桦酸(23-HBA)降低阿霉素(DOX)心肌毒性的靶细胞PK/PD机制.方法 ①通过MTT法、Caspase-3活性测定、Hoechst 33342荧光染色等方法检测H9c2细胞的凋亡水平.②细胞摄取和亚细胞组份法实验考察DOX与DOX-ol在H9c2细胞内的累积、亚细胞器分布及23-HBA的影响.③H9c2细胞胞浆与微粒体的体外温孵实验考察23-H
会议
会议
会议
会议